Weil and Ropes lead on Sanofi’s £12bn Genzyme acquisition
A quartet of international firms has scooped lead roles as French pharmaceutical giant Sanofi-Aventis finalised its $20.1bn (£12.47bn) acquisition of US company Genzyme. Weil Gotshal & Manges consolidated its relationship with Sanofi, fielding a large team on the deal. US-based Michael Aiello, co-head of the firm’s M&A group, led a team of partners working out […]